Methylation-induced silencing of ASC and the effect of expressed ASC on p53-mediated chemosensitivity in colorectal cancer

Ohtsuka Takao, X. F. Liu, Y. Koga, Y. Kitajima, Y. Nakafusa, C. W. Ha, S. W. Lee, K. Miyazaki

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Tumor suppressor p53 is known to play a crucial role in chemosensitivity in colorectal cancer. We previously demonstrated that an apoptosis-associated speck-like protein, ASC, is a p53-target gene which regulates p53-Bax mitochondrial apoptotic pathway. ASC is also known to be a target of methylation-induced gene silencing. An inactivation of ASC might thus cause resistance to chemotherapy, and if this is the case, then the expression of ASC would restore the chemosensitivity. The aim of this study was to clarify this hypothesis. ASC was methylated in 25% of all resected specimens in patients with colorectal cancer; however, ASC methylation did not always correspond to a lack of ASC protein. When expressed in colon cancer cells, in which ASC is absent due to methylation, ASC was found to enhance the chemosensitivity in a p53-dependent manner. In p53-null cells, ASC increased the p53-mediated cell death induced by p53-expressing adenovirus infection. Our data suggest that the methylation-induced silencing of ASC might cause resistance to p53-mediated chemosensitivity in colorectal cancer. The gene introduction of ASC may thus restore such chemosensitivity, and this modality may therefore be a useful new treatment strategy for colorectal cancer.

Original languageEnglish
Pages (from-to)1807-1811
Number of pages5
JournalOncogene
Volume25
Issue number12
DOIs
Publication statusPublished - Mar 16 2006
Externally publishedYes

Fingerprint

Methylation
Colorectal Neoplasms
Adenoviridae Infections
Null Lymphocytes
p53 Genes
Gene Silencing
Colonic Neoplasms
Proteins
Cell Death
Apoptosis
Drug Therapy
Genes
Neoplasms
Therapeutics

All Science Journal Classification (ASJC) codes

  • Molecular Biology
  • Genetics
  • Cancer Research

Cite this

Methylation-induced silencing of ASC and the effect of expressed ASC on p53-mediated chemosensitivity in colorectal cancer. / Takao, Ohtsuka; Liu, X. F.; Koga, Y.; Kitajima, Y.; Nakafusa, Y.; Ha, C. W.; Lee, S. W.; Miyazaki, K.

In: Oncogene, Vol. 25, No. 12, 16.03.2006, p. 1807-1811.

Research output: Contribution to journalArticle

Takao, O, Liu, XF, Koga, Y, Kitajima, Y, Nakafusa, Y, Ha, CW, Lee, SW & Miyazaki, K 2006, 'Methylation-induced silencing of ASC and the effect of expressed ASC on p53-mediated chemosensitivity in colorectal cancer', Oncogene, vol. 25, no. 12, pp. 1807-1811. https://doi.org/10.1038/sj.onc.1209204
Takao, Ohtsuka ; Liu, X. F. ; Koga, Y. ; Kitajima, Y. ; Nakafusa, Y. ; Ha, C. W. ; Lee, S. W. ; Miyazaki, K. / Methylation-induced silencing of ASC and the effect of expressed ASC on p53-mediated chemosensitivity in colorectal cancer. In: Oncogene. 2006 ; Vol. 25, No. 12. pp. 1807-1811.
@article{8ff6d11014c4465a9903683b1cb9b210,
title = "Methylation-induced silencing of ASC and the effect of expressed ASC on p53-mediated chemosensitivity in colorectal cancer",
abstract = "Tumor suppressor p53 is known to play a crucial role in chemosensitivity in colorectal cancer. We previously demonstrated that an apoptosis-associated speck-like protein, ASC, is a p53-target gene which regulates p53-Bax mitochondrial apoptotic pathway. ASC is also known to be a target of methylation-induced gene silencing. An inactivation of ASC might thus cause resistance to chemotherapy, and if this is the case, then the expression of ASC would restore the chemosensitivity. The aim of this study was to clarify this hypothesis. ASC was methylated in 25{\%} of all resected specimens in patients with colorectal cancer; however, ASC methylation did not always correspond to a lack of ASC protein. When expressed in colon cancer cells, in which ASC is absent due to methylation, ASC was found to enhance the chemosensitivity in a p53-dependent manner. In p53-null cells, ASC increased the p53-mediated cell death induced by p53-expressing adenovirus infection. Our data suggest that the methylation-induced silencing of ASC might cause resistance to p53-mediated chemosensitivity in colorectal cancer. The gene introduction of ASC may thus restore such chemosensitivity, and this modality may therefore be a useful new treatment strategy for colorectal cancer.",
author = "Ohtsuka Takao and Liu, {X. F.} and Y. Koga and Y. Kitajima and Y. Nakafusa and Ha, {C. W.} and Lee, {S. W.} and K. Miyazaki",
year = "2006",
month = "3",
day = "16",
doi = "10.1038/sj.onc.1209204",
language = "English",
volume = "25",
pages = "1807--1811",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "12",

}

TY - JOUR

T1 - Methylation-induced silencing of ASC and the effect of expressed ASC on p53-mediated chemosensitivity in colorectal cancer

AU - Takao, Ohtsuka

AU - Liu, X. F.

AU - Koga, Y.

AU - Kitajima, Y.

AU - Nakafusa, Y.

AU - Ha, C. W.

AU - Lee, S. W.

AU - Miyazaki, K.

PY - 2006/3/16

Y1 - 2006/3/16

N2 - Tumor suppressor p53 is known to play a crucial role in chemosensitivity in colorectal cancer. We previously demonstrated that an apoptosis-associated speck-like protein, ASC, is a p53-target gene which regulates p53-Bax mitochondrial apoptotic pathway. ASC is also known to be a target of methylation-induced gene silencing. An inactivation of ASC might thus cause resistance to chemotherapy, and if this is the case, then the expression of ASC would restore the chemosensitivity. The aim of this study was to clarify this hypothesis. ASC was methylated in 25% of all resected specimens in patients with colorectal cancer; however, ASC methylation did not always correspond to a lack of ASC protein. When expressed in colon cancer cells, in which ASC is absent due to methylation, ASC was found to enhance the chemosensitivity in a p53-dependent manner. In p53-null cells, ASC increased the p53-mediated cell death induced by p53-expressing adenovirus infection. Our data suggest that the methylation-induced silencing of ASC might cause resistance to p53-mediated chemosensitivity in colorectal cancer. The gene introduction of ASC may thus restore such chemosensitivity, and this modality may therefore be a useful new treatment strategy for colorectal cancer.

AB - Tumor suppressor p53 is known to play a crucial role in chemosensitivity in colorectal cancer. We previously demonstrated that an apoptosis-associated speck-like protein, ASC, is a p53-target gene which regulates p53-Bax mitochondrial apoptotic pathway. ASC is also known to be a target of methylation-induced gene silencing. An inactivation of ASC might thus cause resistance to chemotherapy, and if this is the case, then the expression of ASC would restore the chemosensitivity. The aim of this study was to clarify this hypothesis. ASC was methylated in 25% of all resected specimens in patients with colorectal cancer; however, ASC methylation did not always correspond to a lack of ASC protein. When expressed in colon cancer cells, in which ASC is absent due to methylation, ASC was found to enhance the chemosensitivity in a p53-dependent manner. In p53-null cells, ASC increased the p53-mediated cell death induced by p53-expressing adenovirus infection. Our data suggest that the methylation-induced silencing of ASC might cause resistance to p53-mediated chemosensitivity in colorectal cancer. The gene introduction of ASC may thus restore such chemosensitivity, and this modality may therefore be a useful new treatment strategy for colorectal cancer.

UR - http://www.scopus.com/inward/record.url?scp=33645017320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645017320&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1209204

DO - 10.1038/sj.onc.1209204

M3 - Article

C2 - 16331272

AN - SCOPUS:33645017320

VL - 25

SP - 1807

EP - 1811

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 12

ER -